DE69614150D1 - Optisch aktive phenylpyrimidin-derivat als schmerzlinderndes mittel - Google Patents

Optisch aktive phenylpyrimidin-derivat als schmerzlinderndes mittel

Info

Publication number
DE69614150D1
DE69614150D1 DE69614150T DE69614150T DE69614150D1 DE 69614150 D1 DE69614150 D1 DE 69614150D1 DE 69614150 T DE69614150 T DE 69614150T DE 69614150 T DE69614150 T DE 69614150T DE 69614150 D1 DE69614150 D1 DE 69614150D1
Authority
DE
Germany
Prior art keywords
optically active
pain relief
phenylpyrimidine derivative
active phenylpyrimidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69614150T
Other languages
English (en)
Other versions
DE69614150T2 (de
Inventor
Malcolm Stuart Nobbs
Sandra Jane Rodgers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69614150D1 publication Critical patent/DE69614150D1/de
Publication of DE69614150T2 publication Critical patent/DE69614150T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
DE69614150T 1995-09-05 1996-09-03 Optisch aktive phenylpyrimidin-derivat als schmerzlinderndes mittel Expired - Lifetime DE69614150T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518027.9A GB9518027D0 (en) 1995-09-05 1995-09-05 Pharmacologically active compound
PCT/EP1996/003856 WO1997009317A2 (en) 1995-09-05 1996-09-03 Optically active phenyl pyrimidine derivative as analgesic agent

Publications (2)

Publication Number Publication Date
DE69614150D1 true DE69614150D1 (de) 2001-08-30
DE69614150T2 DE69614150T2 (de) 2001-11-22

Family

ID=10780172

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614150T Expired - Lifetime DE69614150T2 (de) 1995-09-05 1996-09-03 Optisch aktive phenylpyrimidin-derivat als schmerzlinderndes mittel

Country Status (32)

Country Link
US (1) US6124308A (de)
EP (1) EP0879230B1 (de)
JP (1) JPH11512108A (de)
KR (1) KR19990044397A (de)
CN (1) CN1200729A (de)
AP (1) AP640A (de)
AR (1) AR004192A1 (de)
AT (1) ATE203523T1 (de)
AU (1) AU710091B2 (de)
BG (1) BG65102B1 (de)
BR (1) BR9610388A (de)
CA (1) CA2230362A1 (de)
CO (1) CO4750651A1 (de)
CZ (1) CZ65598A3 (de)
DE (1) DE69614150T2 (de)
EA (1) EA000695B1 (de)
ES (1) ES2160834T3 (de)
GB (1) GB9518027D0 (de)
HR (1) HRP960399A2 (de)
HU (1) HUP9901260A3 (de)
ID (1) ID17274A (de)
IL (1) IL123414A0 (de)
IS (1) IS4673A (de)
NO (1) NO980923L (de)
NZ (1) NZ318390A (de)
PL (1) PL325329A1 (de)
SK (1) SK28598A3 (de)
TR (1) TR199800386T1 (de)
TW (1) TW367326B (de)
WO (1) WO1997009317A2 (de)
YU (1) YU49796A (de)
ZA (1) ZA967466B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016212A1 (es) * 1998-04-28 2001-06-20 Astra Ab Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
AU4550699A (en) * 1998-06-08 1999-12-30 Advanced Medicine, Inc. Multibinding agents that modulate the 5-ht transporter
GB9907965D0 (en) * 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
CA2416819C (en) * 2000-07-21 2011-03-22 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1390355A4 (de) 2001-02-27 2005-02-23 Teva Pharma Neue kristalline formen von lamotrigin und verfahren zu deren herstellung
EP2266590A3 (de) 2002-02-22 2011-04-20 Shire LLC Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
US20050238724A1 (en) * 2002-04-23 2005-10-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
CA2514574A1 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
EP2129381A1 (de) 2007-01-24 2009-12-09 Glaxo Group Limited Pharmazeutische zubereitungen enthaltend 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazin or r(-)-2,4-diamino-5-(2,3dichlorophenyl)-6-fluoromethyl pyrimidin und einen nk1- rezeptor-antagonisten
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.

Also Published As

Publication number Publication date
AR004192A1 (es) 1998-11-04
EA199800189A1 (ru) 1998-10-29
AP640A (en) 1998-04-14
HRP960399A2 (en) 1998-04-30
MX9801680A (es) 1998-05-31
CA2230362A1 (en) 1997-03-13
ID17274A (id) 1997-12-18
CN1200729A (zh) 1998-12-02
AU6986596A (en) 1997-03-27
BG65102B1 (bg) 2007-02-28
EP0879230B1 (de) 2001-07-25
US6124308A (en) 2000-09-26
CO4750651A1 (es) 1999-03-31
PL325329A1 (en) 1998-07-20
EP0879230A2 (de) 1998-11-25
HUP9901260A2 (hu) 1999-09-28
NZ318390A (en) 1999-02-25
GB9518027D0 (en) 1995-11-08
IS4673A (is) 1998-02-23
HUP9901260A3 (en) 2001-04-28
WO1997009317A3 (en) 1997-04-03
WO1997009317A2 (en) 1997-03-13
NO980923L (no) 1998-05-04
DE69614150T2 (de) 2001-11-22
TW367326B (en) 1999-08-21
NO980923D0 (no) 1998-03-04
JPH11512108A (ja) 1999-10-19
ES2160834T3 (es) 2001-11-16
TR199800386T1 (xx) 1998-05-21
KR19990044397A (ko) 1999-06-25
AU710091B2 (en) 1999-09-16
AP9600857A0 (en) 1996-10-31
BG102342A (en) 1998-09-30
BR9610388A (pt) 1999-07-06
EA000695B1 (ru) 2000-02-28
IL123414A0 (en) 1998-09-24
YU49796A (sh) 1999-07-28
SK28598A3 (en) 1998-09-09
ATE203523T1 (de) 2001-08-15
CZ65598A3 (cs) 1998-07-15
ZA967466B (en) 1998-04-06

Similar Documents

Publication Publication Date Title
NL1003300A1 (nl) Implanteerbare therapeutische inrichting.
DE69627539T2 (de) Verpackungsfreie bioelektrode
DE69428080D1 (de) Optisch aktive 2-Imidazoline-5-one-Derivate als Fungizide
DE59603366D1 (de) Hydraulikaggregat
ATE229944T1 (de) Benzooxazine als antimikrobielle mittel
DE69615631D1 (de) Kultivator
ATE203523T1 (de) Optisch aktive phenylpyrimidin-derivat als schmerzlinderndes mittel
SG64394A1 (en) Photo-cross-linkable optically active compounds
DE69520235D1 (de) Schweisshemmende mittel
DE69606665T2 (de) N-Acyl-2-arylcyclopropylmethylamin-Derivate als melatonergisches Mittel
DE29519941U1 (de) Hydraulisches Pumpenaggregat
ATE187165T1 (de) Benzophenonhydrazon-derivate als insektizide
FR2737078B1 (fr) Elagueur portatif hydraulique
DE59508099D1 (de) Hydraulikaggregat
FI973423A0 (fi) Laserkäsittelyjärjestelmä
KR970024395U (ko) 어큐뮬레이터
GB9518188D0 (en) Optically active derivative
KR980003238U (ko) 질통받침대
KR960036593U (ko) 캔 압착기
DE29508024U1 (de) Implantierbare Einrichtung
KR970000421U (ko) 등판기능 휠체어
KR970004073U (ko) 온돌 보료
BR7502026U (pt) Maquete relevo
KR970028910U (ko) 방진 가능한 어큐물레이터
BR9501953A (pt) Estimulador facial